Critical role for osteopontin in diabetic nephropathy (Q43174450)

15 November 2017

Critical role for osteopontin in diabetic nephropathy (English)

1 reference

15 November 2017

Susanne B Nicholas

1

1 reference

15 November 2017

Joey Liu

2

1 reference

15 November 2017

Jason Kim

3

1 reference

15 November 2017

Yuelan Ren

4

1 reference

15 November 2017

Alan R Collins

5

1 reference

15 November 2017

Lam Nguyen

6

1 reference

15 November 2017

Willa A Hsueh

7

1 reference

15 November 2017

language of work or name

English

0 references

publication date

3 February 2010

1 reference

15 November 2017

1 reference

15 November 2017

77

1 reference

15 November 2017

7

1 reference

15 November 2017

588-600

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2009.518

15 November 2017

0 references

cites work

Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Vascular calcification: in vitro evidence for the role of inorganic phosphate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Osteopontin expression in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Molecular Profiling of Diabetic Mouse Kidney Reveals Novel Genes Linked to Glomerular Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

PPARgamma ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Troglitazone, a PPARgamma ligand, inhibits osteopontin gene expression in human monocytes/macrophage THP-1 cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Mouse models of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

The c-jun kinase/stress-activated pathway: regulation, function and role in human disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

MG63 osteoblastic cell adhesion to the hydrophobic surface precoated with recombinant osteopontin fragments

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Diabetic nephropathy: of mice and men.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Peroxisome proliferator-activated receptor-gamma in the renal mesangium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

c-Fos-driven transcriptional activation of transforming growth factor β-1: inhibition of high glucose-induced promoter activity by thiazolidinediones

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Hyperglycemia-induced alteration of vascular smooth muscle phenotype

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Osteopontin: correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

The renal tubulointerstitium in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

PPAR-gamma agonist protects podocytes from injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

The podocyte's response to injury: role in proteinuria and glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Transcription factors in asthma: are transcription factors a new target for asthma therapy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Trichostatin A activates the osteopontin gene promoter through AP1 site

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Trophic factors and cytokines in early diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

P38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Effects of cyclosporine in osteopontin null mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Cellular events in the evolution of experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Eplerenone: selective aldosterone antagonism in management of cardiovascular and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Altered wound healing in mice lacking a functional osteopontin gene (spp1).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Isolated glomeruli and cultured mesangial cells as in vitro models to study immunosuppressive agents

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.518

7 January 2021

Identifiers

DOI

10.1038/KI.2009.518

1 reference

15 November 2017

1 reference